The GLP is committed to full transparency. Download and review our 2019 Annual Report

New GM omega-3 seeds approved for trials in Britain

| | April 17, 2014

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Permission has been granted by the British department of environment, food and rural affairs for the planting of a genetically modified plant that produces seeds rich in omega-3 oils.

The trials of the GM-modified camelina sativa plant at Rothamsted Research in Hertfordshire, which is headed by the Co Monaghan-born Dr Maurice Moloney, will start in the coming weeks and run until 2017.

Conditions have been imposed to ensure the trials are conducted safely, Defra said last night, adding that the plants will not be allowed to enter the food or feed chain. However, the trials are still likely cause controversy.

Read the full, original article: British firm gets go-ahead for planting genetically modified omega-3 seeds

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend